Esketamine Hydrochloride
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Esketamine Hydrochloride is used to treat treatment-resistant depressive disorder, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Mar 5, 2019.
Esketamine Hydrochloride is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $426.30 to $431.23 per EA — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$426.30 – $431.23
per EA
7d Activity
avg -0.1% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ESKETAMINE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SPRAVATO 84 MG DOSE PACK | $431.2278 per EA | -0.13% |
SPRAVATO 56 MG DOSE PACK | $426.2990 per EA | — |
Frequently Asked Questions
What is Esketamine Hydrochloride used to treat?
Esketamine Hydrochloride is used to treat treatment-resistant depressive disorder, per the National Library of Medicine's MED-RT classification.
How many Esketamine Hydrochloride products are on the market?
The Esketamine Hydrochloride drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Esketamine Hydrochloride?
NADAC reference prices for Esketamine Hydrochloride range from $426.2990 to $431.2278 per EA — a 1% difference between cheapest and most expensive.
Which manufacturers make Esketamine Hydrochloride?
1 manufacturer lists Esketamine Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Janssen Pharmaceuticals Inc. (2).
How has the price of Esketamine Hydrochloride changed recently?
Over the past 7 days, 0 Esketamine Hydrochloride NDCs rose and 1 fell, with a market-wide average change of -0.1%.